23andMe Holding Co. - stock earnings
ME Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 26, 2024 BeforeMarket | - / -0.1500000000 | - | - / 55.8 million | - |
ME Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -278.0 million USD | 44.7 million USD |
| 2023Q3 | -75.3 million USD | 50.0 million USD |
| 2023Q2 | -104.6 million USD | 60.9 million USD |
| 2023Q1 | -64.1 million USD | 92.4 million USD |
| 2022Q4 | -92.0 million USD | 66.9 million USD |
| 2022Q3 | -66.1 million USD | 75.7 million USD |
| 2022Q2 | -89.5 million USD | 64.5 million USD |
| 2022Q1 | -69.5 million USD | 100.6 million USD |
| 2021Q4 | -89.4 million USD | 56.9 million USD |
| 2021Q3 | -16.5 million USD | 55.2 million USD |
| 2021Q2 | -42.0 million USD | 59.2 million USD |
| 2021Q1 | -67.0 million USD | 88.6 million USD |
| 2020Q4 | -44.6 million USD | 55.5 million USD |
| 2020Q3 | -36.2 million USD | 51.8 million USD |
| 2020Q2 | -35.8 million USD | 48.1 million USD |
ME Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -311.7 million USD | 299.5 million USD |
| 2022 | -217.5 million USD | 271.9 million USD |
| 2021 | -183.4 million USD | 243.9 million USD |
| 2020 | -289.3 million USD | 305.5 million USD |
| 2019 | -183.5 million USD | 440.9 million USD |
ME
Price: $0.46
52 week price:
Earnings Per Share: -1.11 USD
P/E Ratio: -0.96
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.6 million
Market Capitalization: 231.3 million